Manuka (Manuka) Risk Assessment

View and export this data going back to 2023. Start your Free Trial

What is Manuka Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Manuka is: No Data: Cannot be evaluated.

Competitive Comparison of Manuka's Risk Assessment

For the Household & Personal Products subindustry, Manuka's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Manuka's Risk Assessment Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Manuka's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Manuka's Risk Assessment falls into.

Manuka (OTCPK:MNKA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Manuka Risk Assessment Related Terms

Thank you for viewing the detailed overview of Manuka's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Manuka (Manuka) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Manuka Inc (OTCPK:MNKA) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Eliezer Vardinon Street, Petach Tikva, ISR, 4959507

Website

https://www.bmanuka.co.il

Manuka Inc is a beauty company that develops and distributes premium-quality skincare products, that are based on M?nuka honey and bee venom. Its skincare products are manufactured in Israel by its vendor, Chic with M?nuka honey ingredients. The company imports Manuka honey from its supplier in New Zealand, Waitemata Honey pursuant to the Supply Agreement. Currently, it operates only in Israel through the online platform. Its website and mobile applications currently offer six cosmetic skincare products: Face Serum with Manuka Honey and Bee Venom; Face Serum with enhanced Vitamin C; Day Cream; Night nourishing Cream; Eye Cream; and Face Cleanser Gel.

Executives

David Dana	officer: Chief Financial Officer	3 ELIEZER VARDINON ST., PETACH TIKVA L3 4959507
Shimon Citron	director, officer: Chief Executive Officer
Brian M Culley	officer: Chief Executive Officer	6725 MESA RIDGE ROAD, SUITE 100, SAN DIEGO CA 92121
Peter N. Payne	officer: Chief Executive Officer	C/O NEW YORK GLOBAL INNOVATIONS INC., 18 E. 16TH STREET, SUITE 307, NEW YORK NY 10003
Dana Wolf	officer: Chief Scientific Officer	18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Tonak Ltd.	10 percent owner	18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Israel Alfassi	director	18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Chanan Morris	officer: Chief Financial Officer	30 HAKTORET STREET, EFRAT L3 90435
Arias Roberto Alonso Jimenez	director	C/O NEW YORK GLOBAL INNOVATIONS INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
Tomer Assis	officer: Chief Financial Officer	C/O INKSURE TECHNOLOGIES INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
David W Sass	director, officer: Secretary	260 MADISON AVE 18TH FLR, NEW YORK NY 10016
David Avner	officer: CHIEF FINANCIAL OFFICER	1 HAMADA ST, REHOVOT L3 76703
Jonathan Bettsak	director	C/O INKSURE LTD 1 HAMADA ST., THE RABIN SCIENCE PARK, REHOVOT L3 76703
Tal Gilat	officer: President and CEO	C/O INKSURE, 1 HAMADA ST., REHOVOT L3 76703
Alon Raich	director	C/O ICTS INTERNATIONAL, N.V., BIESBOSCH 225, 1181 JC AMSTELVEEN P7 0000000000

Manuka (Manuka) Headlines

No Headlines